Applied DNA Sciences (NASDAQ:APDN) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a report released on Monday. The firm set a “hold” rating on the technology company’s stock.

Separately, HC Wainwright decreased their price target on Applied DNA Sciences from $40.00 to $30.00 and set a “buy” rating for the company in a research note on Friday, February 9th.

Applied DNA Sciences Price Performance

Shares of NASDAQ APDN opened at $4.01 on Monday. The business has a fifty day moving average price of $8.79 and a 200 day moving average price of $12.63. Applied DNA Sciences has a 1-year low of $3.60 and a 1-year high of $37.20. The stock has a market capitalization of $3.41 million, a P/E ratio of -0.37 and a beta of 0.07.

Applied DNA Sciences (NASDAQ:APDN) last issued its quarterly earnings data on Thursday, February 8th. The technology company reported ($1.80) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($6.20) by $4.40. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. The firm had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. As a group, equities research analysts anticipate that Applied DNA Sciences will post -12.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC purchased a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences as of its most recent filing with the Securities and Exchange Commission. 22.22% of the stock is currently owned by institutional investors and hedge funds.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.